Business Context and Reporting Period
This Form 8-K is a current report filed by Iradimed Corporation on April 7, 2020. The filing addresses Item 8.01 (Other Events) regarding the Company's financial outlook for the first quarter and full year of 2020.
Key Financial Metrics
- Q1 2020 Revenue Expectation: The Company expects to report revenue between $8.6 million and $8.7 million for the quarter ended March 31, 2020.
- Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide specific values for net income, operating cash flow, profit margins, debt levels, or liquidity ratios.
Material Changes and Guidance
On April 7, 2020, the Company issued a press release announcing a significant change to its financial outlook:
- Guidance Withdrawal: Iradimed is withdrawing its previously issued financial guidance for both the quarter ended March 31, 2020, and the full year ending December 31, 2020.
- Reasoning: The filing text does not explicitly state the specific operational or market reasons for the withdrawal, though the action implies a material change in the business environment affecting forecastability.
Investor Verification Checklist
- Verify the specific reasons for the withdrawal of full-year 2020 guidance in the attached press release (Exhibit 99.1).
- Confirm the impact of the Q1 revenue range ($8.6M–$8.7M) against prior year Q1 results to assess year-over-year performance.
- Review subsequent filings for updated liquidity and debt positions, as this 8-K does not contain balance sheet data.